Multiple indicators model of long-term mortality in traumatic brain injury

References

• Agliaferri F, Compagnone C, Korsic M, Servadei F, Kraus J. A systematic review of brain injury epidemiology in Europe. Acta Neurochirurgica 2006; 148: 255–268
   PubMedGoogle Scholar
• Steyerberg EW, Mushkudiani N, Perel P, Butcher I, Lu J, McHugh GS, Murray GD, Marmarou A, Roberts I, Habbema JD, Maas AI. Predicting outcome after traumatic brain injury: Development and international validation of prognostic scores based on admission characteristics. PLoS Medicine 2008; 5: e165
   PubMed Web of Science ®Google Scholar
• Collaborators MRC CRASH Trial, Perel P, Arango M, Clayton T, Edwards P, Komolafe E, Poccock S, Roberts I, Shakur H, Steyerberg E, Yutthakasemsunt S. Predicting outcome after traumatic brain injury: Practical prognostic models ssbased on large cohort of international patients. British Medical Journal 2008;336:425–429
   Google Scholar
• Raabe A, Grolms C, Sorge O, Zimmermann M, Seifert V. Serum S-100B protein in severe head injury. Neurosurgery 1999; 45: 477–483
   PubMed Web of Science ®Google Scholar
• Böhmer AE, Oses JP, Schmidt AP, Perón CS, Krebs CL, Oppitz PP, D'Avila TT, Souza DO, Portela LV, Stefani MA. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Neurosurgery 2011; 68: 1624–1631
   PubMed Web of Science ®Google Scholar
• Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H. GFAP versus S100B in serum after traumatic brain injury: Relationship to brain damage and outcome. Journal of Neurotrauma 2004; 21: 1553–1561
   PubMed Web of Science ®Google Scholar
• Wiesmann M, Steinmeier E, Magerkurth O, Linn J, Gottmann D, Missler U. Outcome prediction in traumatic brain injury: Comparison of neurological status, CT findings, and blood levels of S100B and GFAP. Acta Neurologica Scandinavica 2010; 121: 178–185
   PubMed Web of Science ®Google Scholar
• Kochanek PM, Berger RP, Bayir H, Wagner AK, Jenkins LW, Clark RS. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: Diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Current Opinion in Critical Care 2008; 14: 135–141
   PubMed Web of Science ®Google Scholar
• Rainey T, Lesko M, Sacho R, Lecky F, Childs C. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: Results using a single (24h) time-point. Resuscitation 2009; 80: 341–345
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay S, Hennes H, Gorelick MH, Wells RG, Walsh-Kelly CM. Serum neuron-specific enolase as a predictor of short-term outcome in children with closed traumatic brain injury. Academic Emergency Medicine 2005; 12: 732–738
   PubMed Web of Science ®Google Scholar
• Lumpkins KM, Bochicchio GV, Keledjian K, Simard JM, McCunn M, Scalea T. Glial fibrillary acidic protein is highly correlated with brain injury. Journal of Trauma 2008; 65: 778–782
   PubMedGoogle Scholar
• Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A, Manley GT. Classification of traumatic brain injury for targeted therapies. Journal of Neurotrauma 2008; 25: 719–738
   PubMed Web of Science ®Google Scholar
• Vos PE, Jacobs B, Andriessen TM, Lamers KJ, Borm GF, Beems T, Edwards M, Rosmalen CF, Vissers JL. GFAP and S100B are biomarkers of traumatic brain injury: An observational cohort study. Neurology 2010; 75: 1786–1793
   PubMed Web of Science ®Google Scholar
• Mondello S, Papa L, Buki A, Bullock MR, Czeiter E, Tortella FC, Wang KK, Hayes RL. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: A case control study. Critical Care 2011; 15: R156
   PubMed Web of Science ®Google Scholar
• Marshall LF, Bowers-Marshall S, Klauber MR, van Berkum Clark M, Eisenberg HM, Jane JA, Luerssen TG, Marmarou A, Foulkes MA. A new classification of head injury based on computerized tomography. Journal of Neurosurgery 1991; 75(Suppl)S14–20
   Web of Science ®Google Scholar
• Stocchetti N, Croci M, Spagnoli D, Gilardoni F, Resta F, Colombo A. Mass volume measurement in severe head injury: Accuracy and feasibility of two pragmatic methods. Journal of Neurology, Neurosurgery and Psychiatry 2000; 68: 14–17
   PubMedGoogle Scholar
• Brain Trauma Foundation. American Association of Neurological Surgeons, Congress of Neurological Surgeons (2007). Guidelines for management of severe traumatic brain injury. Journal of Neurotrauma 2007; 24(Suppl)1–106
   Google Scholar
• Stocchetti N, Colombo A, Ortolano F, Videtta W, Marchesi R, Longhi L, Zanier ER. Time course of intracranial hypertension after traumatic brain injury. Journal of Neurotrauma 2007; 24: 1339–1346
   PubMed Web of Science ®Google Scholar
• Vissers JL, Mersch ME, Rosmalen CF, van Heumen MJ, van Geel WJ, Lamers KJ, Rosmalen FM, Swinkels LM, Thomsen J, Herrmann M. Rapid immunoassay for the determination of glial fibrillary acidic protein (GFAP) in serum. Clinica Chimica Acta 2006; 366: 336–340
   PubMed Web of Science ®Google Scholar
• Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975; 1: 480–484
   PubMed Web of Science ®Google Scholar
• Altman DG. Practical statistics for medical research1st. Chapman & Hall, London 1990; 365–394
   Google Scholar
• Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW. Assessing the performance of prediction models: A framework for traditional and novel measures. Epidemiology 2010; 21: 128–138
   PubMed Web of Science ®Google Scholar
• Harrell FE, Jr, Lee KL, ., Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Med 1996; 15: 361–387
   PubMed Web of Science ®Google Scholar
• Hukkelhoven CW, Steyerberg EW, Habbema JD, Farace E, Marmarou A, Murray GD, Marshall LF, Maas AI. Predicting outcome after traumatic brain injury: Development and validation of a prognostic score based on admission characteristics. Journal of Neurotrauma 2005; 22: 1025–1039
   PubMed Web of Science ®Google Scholar
• Woertgen C, Rothoerl RD, Metz C, Brawanski A. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. Journal of Trauma 1999; 47: 1126–1130
   PubMed Web of Science ®Google Scholar
• Kleindienst A, Hesse F, Bullock MR, Buchfelder M. The neurotrophic protein S100B: Value as a marker of brain damage and possible therapeutic implications. Progress in Brain Research 2007; 161: 317–325
   PubMed Web of Science ®Google Scholar
• Nylén K, Ost M, Csajbok LZ, Nilsson I, Blennow K, Nellgård B, Rosengren L. Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome. Journal of Neurological Sciences 2006; 240: 85–91
   PubMed Web of Science ®Google Scholar
• Stocchetti N, Pagan F, Calappi E, Canavesi K, Beretta L, Citerio G, Cormio M, Colombo A. Inaccurate early assessment of neurological severity in head injury. Journal of Neurotrauma 2004; 21: 1131–1140
   PubMed Web of Science ®Google Scholar
• Balestreri M, Czosnyka M, Chatfield DA, Steiner LA, Schmidt EA, Smielewski P, Matta B, Pickard JD. Predictive value of Glasgow Coma Scale after brain trauma: Change in trend over the past ten years. Journal of Neurology, Neurosurgery and Psychiatry 2004; 75: 161–162
   PubMed Web of Science ®Google Scholar
• Xu XY, Liu WG, Yang XF, Li LQ. Evaluation of models that predict short-term outcome after traumatic brain injury. Brain Injury 2007; 21: 575–582
   PubMed Web of Science ®Google Scholar
• Lobato RD, Gomez PA, Alday R, Rivas JJ, Dominguez J, Cabrera A, Turanzas FS, Benitez A, Rivero B. Sequential computerized tomography changes and related final outcome in severe head injury patients. Acta Neurochirurgica 1997; 139: 385–391
   PubMed Web of Science ®Google Scholar
• Servadei F, Murray GD, Penny K, Taeasdale GM, Dearden M, Iannotti F, Lapierre F, Maas AJ, Karimi A, Ohman J, et al. The value of the "worst" computed tomographic scan in clinical studies of moderate and severe head injury. European Brain Injury Consortium. Neurosurgery 2000; 46: 70–75
   Google Scholar
• Murillo-Cabezas F, Muñoz-Sánchez MA, Rincón-Ferrari MD, Martín-Rodríguez JF, Amaya-Villar R, García-Gómez S, León-Carrión J. The prognostic value of the temporal course of S100beta protein in post-acute severe brain injury: A prospective and observational study. Brain Injury 2010; 24: 609–619
   PubMed Web of Science ®Google Scholar
• Thelin E, Bellander B. The temporal profiles in serum concentrations of s100b after traumatic brain injury correspond to outcome. Journal of Neurotrauma 2009; 26: A44
   Google Scholar
• Blyth BJ, Farhavar A, Gee C, Hawthorn B, He H, Nayak A, Stöcklein V, Bazarian JJ. Validation of serum markers for blood-brain barrier disruption in traumatic brain injury. Journal of Neurotrauma 2009; 26: 1497–1507
   PubMed Web of Science ®Google Scholar
• Savola O, Pyhtinen J, Leino TK, Siitonen S, Niemelä O, Hillbom M. Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. Journal of Trauma 2004; 56: 1229–1234
   PubMed Web of Science ®Google Scholar